Berenberg Bank set a €124.00 ($145.88) target price on Bayer AG (FRA:BAYN) in a research report released on Friday morning. The firm currently has a neutral rating on the healthcare company’s stock.

Several other brokerages also recently issued reports on BAYN. Citigroup Inc. set a €130.00 ($152.94) price target on shares of Bayer AG and gave the company a buy rating in a report on Thursday, October 5th. Independent Research GmbH set a €120.00 ($141.18) price target on shares of Bayer AG and gave the company a neutral rating in a report on Thursday, July 27th. Deutsche Bank AG set a €124.00 ($145.88) price target on shares of Bayer AG and gave the company a buy rating in a report on Monday, August 28th. Kepler Capital Markets set a €102.00 ($120.00) price target on shares of Bayer AG and gave the company a neutral rating in a report on Monday, August 28th. Finally, Sanford C. Bernstein set a €126.00 ($148.24) price target on shares of Bayer AG and gave the company a buy rating in a report on Friday, October 6th. Eight research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Bayer AG currently has an average rating of Buy and a consensus target price of €122.38 ($143.98).

Shares of Bayer AG (FRA BAYN) opened at €116.65 ($137.24) on Friday. Bayer AG has a twelve month low of €85.72 ($100.85) and a twelve month high of €123.82 ($145.67).

COPYRIGHT VIOLATION NOTICE: “Berenberg Bank Analysts Give Bayer AG (BAYN) a €124.00 Price Target” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/berenberg-bank-analysts-give-bayer-ag-bayn-a-124-00-price-target/1681905.html.

Bayer AG Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and womenÂ’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.